About
26.81USD+0.04 +0.15%
Closed • Updated at 13:38 GMT+00:00Market Cap$1.43B
Volume5.54M
Beta0.44
RSI75.16
Kalvista Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 29 2026
Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio
Apr 8 2026
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 30 2026
KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference
Mar 25 2026
KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
Mar 20 2026
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference
Translate